Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
453
datasets available to search
ShareScore release 0.9.0
Dataset results
453 results for “Idiopathic pulmonary fibrosis”
Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study
ClinicalTrials.gov study NCT00903331. IPD Sharing: Not stated. Countries: 12. Publications: 1.
A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
ClinicalTrials.gov study NCT02550873. IPD Sharing: Not stated. Countries: 7. Publications: 3.
Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3
ClinicalTrials.gov study NCT02951429. IPD Sharing: Not stated. Countries: 13. Publications: 2.
A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
ClinicalTrials.gov study NCT03832946. IPD Sharing: NO. Countries: 15. Publications: 2.
A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
ClinicalTrials.gov study NCT04419506. IPD Sharing: YES. Countries: 22. Publications: 1.
A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care
ClinicalTrials.gov study NCT03733444. IPD Sharing: NO. Countries: 15. Publications: 4.
Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis
ClinicalTrials.gov study NCT01214187. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis
ClinicalTrials.gov study NCT04552899. IPD Sharing: YES. Countries: 35. Publications: 3.
Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)
ClinicalTrials.gov study NCT02598193. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II
ClinicalTrials.gov study NCT01335477. IPD Sharing: Not stated. Countries: 17. Publications: 14.
Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
ClinicalTrials.gov study NCT03955146. IPD Sharing: UNDECIDED. Countries: 9. Publications: 2.
Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment
ClinicalTrials.gov study NCT02802345. IPD Sharing: Not stated. Countries: 13. Publications: 3.
Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients
ClinicalTrials.gov study NCT01335464. IPD Sharing: Not stated. Countries: 13. Publications: 14.
A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough
ClinicalTrials.gov study NCT04030026. IPD Sharing: NO. Countries: 1. Publications: 1.
Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment
ClinicalTrials.gov study NCT02788474. IPD Sharing: YES. Countries: 13. Publications: 4.
Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
ClinicalTrials.gov study NCT01366209. IPD Sharing: Not stated. Countries: 1. Publications: 17.
Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
ClinicalTrials.gov study NCT01890265. IPD Sharing: Not stated. Countries: 7. Publications: 3.
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)
ClinicalTrials.gov study NCT05938920. IPD Sharing: NO. Countries: 1. Publications: 1.
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
ClinicalTrials.gov study NCT01979952. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
ClinicalTrials.gov study NCT00662038. IPD Sharing: Not stated. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.